• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潜在的诊断和预后标志物二甲基甘氨酸脱氢酶(DMGDH)在体外和体内均可抑制肝细胞癌转移。

Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo.

作者信息

Liu Gang, Hou Guojun, Li Liang, Li Yixue, Zhou Weiping, Liu Lei

机构信息

Key Laboratory of Systems Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.

The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

出版信息

Oncotarget. 2016 May 31;7(22):32607-16. doi: 10.18632/oncotarget.8927.

DOI:10.18632/oncotarget.8927
PMID:27119355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5078037/
Abstract

Key metabolic enzymes regulatethe fluxes of small compounds to provide the basal substrates for cellular architecture and energy. Some of them are reported to be important carcinogenesis- and metastasis-related genes. In our work, we performed RNA-seq for50 pairs of normal-tumor of hepatocellular carcinoma (HCC) samples and found that the expression of dimethylglycine dehydrogenase (DMGDH) is decreased in HCC. The analysis of protein levels with Western blotting and immunohistochemistry also conformed our findings. It is proven to be a valuable biomarker for both diagnosis and prognosis in three independent datasets. Furthermore, we revealed that DMGDH suppresses migration, invasion and metastasis both in vitro and in vivo. By utilizing gene expression microarray for DMGDH, we identified several possible pathways altered in a DMGDH over-expressing cell line. Among these pathways, we noted that the phosphorylation of Akt-308/473 was significantly suppressed when DMGDH was over-expressed. In summary, our work reveals that DMGDH is a potential valuable biomarker for both diagnosis and prognosisfor HCC, and DMGDH gene expression suppresses metastasis through the Akt signaling pathway.

摘要

关键代谢酶调节小分子化合物的通量,为细胞结构和能量提供基础底物。据报道,其中一些酶是重要的致癌和转移相关基因。在我们的研究中,我们对50对肝细胞癌(HCC)正常肿瘤样本进行了RNA测序,发现二甲基甘氨酸脱氢酶(DMGDH)在HCC中的表达降低。蛋白质印迹和免疫组织化学对蛋白质水平的分析也证实了我们的发现。在三个独立数据集中,它被证明是一种有价值的诊断和预后生物标志物。此外,我们发现DMGDH在体外和体内均能抑制迁移、侵袭和转移。通过对DMGDH进行基因表达微阵列分析,我们在过表达DMGDH的细胞系中鉴定了几种可能发生改变的途径。在这些途径中,我们注意到当DMGDH过表达时,Akt-308/473的磷酸化被显著抑制。总之,我们的研究表明,DMGDH是一种潜在的有价值的HCC诊断和预后生物标志物,并且DMGDH基因表达通过Akt信号通路抑制转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/c349380920db/oncotarget-07-32607-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/272c221c5f1c/oncotarget-07-32607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/0d7b6866989b/oncotarget-07-32607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/360d4ec0c193/oncotarget-07-32607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/8924be814eee/oncotarget-07-32607-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/c349380920db/oncotarget-07-32607-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/272c221c5f1c/oncotarget-07-32607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/0d7b6866989b/oncotarget-07-32607-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/360d4ec0c193/oncotarget-07-32607-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/8924be814eee/oncotarget-07-32607-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf0/5078037/c349380920db/oncotarget-07-32607-g005.jpg

相似文献

1
Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo.潜在的诊断和预后标志物二甲基甘氨酸脱氢酶(DMGDH)在体外和体内均可抑制肝细胞癌转移。
Oncotarget. 2016 May 31;7(22):32607-16. doi: 10.18632/oncotarget.8927.
2
High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma.含己糖激酶结构域1的高表达与肝癌的不良预后和侵袭性表型相关。
Biochem Biophys Res Commun. 2016 Jun 10;474(4):673-679. doi: 10.1016/j.bbrc.2016.05.007. Epub 2016 May 4.
3
Folate in demethylation: the crystal structure of the rat dimethylglycine dehydrogenase complexed with tetrahydrofolate.甲硫氨酸在去甲基化中的作用:与四氢叶酸复合物结合的大鼠二甲基甘氨酸脱氢酶的晶体结构。
Biochem Biophys Res Commun. 2014 Jul 11;449(4):392-8. doi: 10.1016/j.bbrc.2014.05.064. Epub 2014 May 22.
4
Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.Nek7在肝细胞癌中过度表达,并在体外和体内促进肝癌细胞增殖。
Oncotarget. 2016 Apr 5;7(14):18620-30. doi: 10.18632/oncotarget.7620.
5
Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.长链非编码RNA CPS1-IT1通过调节HIF-1α活性和抑制上皮-间质转化来抑制肝细胞癌的转移。
Oncotarget. 2016 Jul 12;7(28):43588-43603. doi: 10.18632/oncotarget.9635.
6
MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.微小RNA-7下调癌基因电压依赖性阴离子通道蛋白1以影响肝细胞癌的增殖和转移。
Tumour Biol. 2016 Aug;37(8):10235-46. doi: 10.1007/s13277-016-4836-1. Epub 2016 Jan 30.
7
Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.冠层同源物2表达可预测伴有肿瘤出血的肝细胞癌预后不良。
Cell Physiol Biochem. 2018;50(6):2017-2028. doi: 10.1159/000495048. Epub 2018 Nov 9.
8
Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.提示1通过调节Girdin活性在体外抑制肝癌细胞的迁移和侵袭。
Tumour Biol. 2016 Nov;37(11):14711-14719. doi: 10.1007/s13277-016-5336-z. Epub 2016 Sep 14.
9
miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.微小RNA-149通过靶向肌动蛋白调节蛋白PPM1F抑制肝细胞癌转移。
Oncotarget. 2015 Nov 10;6(35):37808-23. doi: 10.18632/oncotarget.5676.
10
Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma.神经氨酸酶1(NEU1)作为肝细胞癌的诊断和预后生物标志物,可促进细胞增殖和迁移。
Oncotarget. 2016 Oct 4;7(40):64957-64966. doi: 10.18632/oncotarget.11778.

引用本文的文献

1
as a Liver-Specific Biomarker for Hepatocellular Carcinoma: Diagnostic and Prognostic Implications.作为肝细胞癌的肝脏特异性生物标志物:诊断和预后意义
Curr Issues Mol Biol. 2025 Jul 18;47(7):563. doi: 10.3390/cimb47070563.
2
Comprehensive transcriptomic analysis of hepatocellular Carcinoma: Uncovering shared and unique molecular signatures across diverse etiologies.肝细胞癌的综合转录组分析:揭示不同病因下共有的和独特的分子特征。
Biochem Biophys Rep. 2025 Jun 30;43:102123. doi: 10.1016/j.bbrep.2025.102123. eCollection 2025 Sep.
3
An integrated bioinformatic investigation of succinic acid metabolism related genes in ccRCC followed by preliminary validation of SLC25A4 in tumorigenesis.

本文引用的文献

1
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.谷氨酰胺酶2负向调节PI3K/AKT信号通路,并在人肝细胞癌中显示出肿瘤抑制活性。
Oncotarget. 2014 May 15;5(9):2635-47. doi: 10.18632/oncotarget.1862.
2
Activation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin.AMP 激活的蛋白激酶的激活可减轻脂联素抵抗素刺激的肝癌细胞黏附。
BMC Cancer. 2014 Feb 20;14:112. doi: 10.1186/1471-2407-14-112.
3
Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning.
对ccRCC中琥珀酸代谢相关基因进行综合生物信息学研究,随后对SLC25A4在肿瘤发生中的作用进行初步验证。
Sci Rep. 2025 Jun 5;15(1):19736. doi: 10.1038/s41598-025-03102-8.
4
MRAS: Master Regulator Analysis of Alternative Splicing.MRAS:可变剪接的主调控因子分析
Adv Sci (Weinh). 2025 Jun;12(21):e2414493. doi: 10.1002/advs.202414493. Epub 2025 May 5.
5
Biosocial Determinants of Health Among Patients with Chronic Liver Disease and Liver Cancer.慢性肝病和肝癌患者健康的生物社会决定因素
Cancers (Basel). 2025 Feb 28;17(5):844. doi: 10.3390/cancers17050844.
6
Computational discovery of co-expressed antigens as dual targeting candidates for cancer therapy through bulk, single-cell, and spatial transcriptomics.通过批量、单细胞和空间转录组学计算发现共表达抗原作为癌症治疗的双重靶向候选物。
Bioinform Adv. 2024 Jun 20;4(1):vbae096. doi: 10.1093/bioadv/vbae096. eCollection 2024.
7
ADARp110 promotes hepatocellular carcinoma progression via stabilization of CD24 mRNA.ADARp110通过稳定CD24信使核糖核酸促进肝细胞癌进展。
Proc Natl Acad Sci U S A. 2025 Jan 21;122(3):e2409724122. doi: 10.1073/pnas.2409724122. Epub 2025 Jan 14.
8
Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma.肝癌多组学研究揭示多种蛋白激酶A破坏作用会共同导致纤维板层型肝细胞癌。
Nat Commun. 2024 Dec 30;15(1):10887. doi: 10.1038/s41467-024-55238-2.
9
A predicted epithelial-to-mesenchymal transition-associated mRNA/miRNA axis contributes to the progression of diabetic liver disease.一个预测的上皮间质转化相关的 mRNA/miRNA 轴有助于糖尿病肝疾病的进展。
Sci Rep. 2024 Nov 12;14(1):27678. doi: 10.1038/s41598-024-77416-4.
10
Functional remodeling of gut microbiota and liver in laying hens as affected by fasting and refeeding after fasting.禁食及禁食后重新喂食对蛋鸡肠道微生物群和肝脏的功能重塑
Anim Biosci. 2025 Apr;38(4):692-706. doi: 10.5713/ab.24.0299. Epub 2024 Oct 28.
2013年的肝癌:肝细胞癌的突变图谱——开端的结束。
Nat Rev Clin Oncol. 2014 Feb;11(2):73-4. doi: 10.1038/nrclinonc.2013.243. Epub 2014 Jan 7.
4
The UCSC Genome Browser database: 2014 update.UCSC 基因组浏览器数据库:2014 年更新。
Nucleic Acids Res. 2014 Jan;42(Database issue):D764-70. doi: 10.1093/nar/gkt1168. Epub 2013 Nov 21.
5
Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma.硬脂酰辅酶 A 去饱和酶在人肝癌的增殖和化疗耐药中起重要作用。
J Surg Res. 2014 Jan;186(1):29-38. doi: 10.1016/j.jss.2013.07.001. Epub 2013 Jul 27.
6
Primary hepatocellular carcinoma and metabolic syndrome: An update.原发性肝细胞癌与代谢综合征:最新研究进展。
World J Gastrointest Oncol. 2013 Sep 15;5(9):186-94. doi: 10.4251/wjgo.v5.i9.186.
7
Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.应用非靶向组织代谢组学对肝细胞癌进行代谢特征分析。
Cancer Res. 2013 Aug 15;73(16):4992-5002. doi: 10.1158/0008-5472.CAN-13-0308. Epub 2013 Jul 1.
8
Dual roles of PKM2 in cancer metabolism.PKM2 在癌症代谢中的双重作用。
Acta Biochim Biophys Sin (Shanghai). 2013 Jan;45(1):27-35. doi: 10.1093/abbs/gms106. Epub 2012 Dec 4.
9
Metabolic syndrome and hepatocellular carcinoma risk.代谢综合征与肝细胞癌风险。
Br J Cancer. 2013 Jan 15;108(1):222-8. doi: 10.1038/bjc.2012.492. Epub 2012 Nov 20.
10
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks.RNA-seq 实验中使用 TopHat 和 Cufflinks 的差异基因和转录本表达分析。
Nat Protoc. 2012 Mar 1;7(3):562-78. doi: 10.1038/nprot.2012.016.